Knight Therapeutics (GUD.TO) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.23
-0.15
-0.07
0.01

Details

Expected EPS
0.01267973186752
Actual EPS
-0.040381311680000004
Surprise EPS
-0.05
Surprise Percent
+418.47%

Description

Knight Therapeutics (GUD.TO) has reported earnings of -0.040381311680000004 per share for Q2 2024.

0 Comments

Share your thoughts